Oct 30 (Reuters) - Cyclerion Therapeutics Inc CYCN.O :
* CYCLERION THERAPEUTICS INC - ON OCT. 29, BOARD APPROVED
REDUCTION OF COMPANY'S CURRENT WORKFORCE BY APPROXIMATELY THIRTY
FULL-TIME EMPLOYEES
* CYCLERION THERAPEUTICS SAYS COMPANY EXPECTS THAT WORKFORCE
REDUCTION WILL TAKE PLACE PRIMARILY DURING Q4 OF 2019 - SEC
FILING
* CYCLERION THERAPEUTICS - ESTIMATES IT WILL INCUR CHARGES
IN
CONNECTION WITH WORKFORCE REDUCTION OF ABOUT $3 MILLION FOR
ONE-TIME EMPLOYEE SEVERANCE, BENIFIT COSTS
* CYCLERION THERAPEUTICS INC - EXPECTS TO REDUCE CASH
OPERATING
EXPENSES BY ABOUT $7 TO $8 MILLION DURING FISCAL YEAR ENDING DEC
31, 2020
Source text: (https://bit.ly/33bLwSU)
Further company coverage: CYCN.O
((Reuters.Briefs@thomsonreuters.com;))